Production is due to begin in the second quarter, with estimated delivery in the third quarter, according to a statement from the company on Friday. The pharma giant will rely on manufacturing facilities at a site in Stein, Switzerland.
Chief Executive Officer
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.